ANRESIS Publikationen
Incidence and Resistance Patterns of Citrobacter spp. in Switzerland: A Nationwide, Retrospective Surveillance Study (2010–2022).
Microorganisms 2025, 13, 786. https://doi.org/10.3390/ microorganisms13040786
Incidence and resistance rates of Pseudomonas aeruginosa bloodstream infections in Switzerland: a nationwide surveillance study (2010–2022)
Infection. 2025 Jan 30. doi: 10.1007/s15010-024-02452-1. Epub ahead of print. PMID: 39883261.
Epidemiology of bloodstream infections caused by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae in Switzerland, 2015–2022: secular trends and association with the COVID-19 pandemic
Journal of Hospital Infection, Volume 150 , August 2024, Pages 145-152.
Für einen besseren Umgang mit Antibiotika
Schweizerische Ärztezeitung | 2024;105(4):29–33
From Hospital-Level to Patient-Level Antibiotic Consumption Data: How Can We Improve Surveillance of AntibioticUse in the Frame of Antibiotic StewardshipProgrammes?
PhD Thesis Graduate School for Health Sciences University of Bern.
Assessing the conversion of electronic medical record data into antibiotic stewardship indicators
Journal of Antimicrobial Chemotherapy, 2023;, dkad235, https://doi.org/10.1093/jac/dkad235
Associated deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland, 2010 to 2019
Euro Surveill. 2023;28(20):pii=2200532. https://doi.org/10.2807/1560-7917.ES.2023.28.20.2200532
Bacterial species and antimicrobial resistance differ between catheter and non–catheter-associated urinary tract infections: Data from a national surveillance network
Antimicrobial Stewardship & Healthcare Epidemiology, 3(1), E55. doi:10.1017/ash.2022.340.
Increase in methicillin-susceptible Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008–2021)
Infection (2023). https://doi.org/10.1007/s15010-023-01980-6.
Antibiotic resistance surveillance of Klebsiella pneumoniae complex is affected by refined MALDI-TOF identification, Swiss data, 2017 to 2022.
Euro Surveill. 2022 Nov;27(45). doi: 10.2807/1560-7917.ES.2022.27.45.2200104. PMID: 36367012.
Air temperature and incidence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae
Environ Res. 2022 Dec;215(Pt 2):114146. doi: 10.1016/j.envres.2022.114146. Epub 2022 Aug 19. PMID: 35988828.
Retrospective data analysis for definition of multidrug resistance in gram-negative bacteria – a consensus proposal.
Swiss Med Wkly. 2022 Jul 11;152:w30195. doi: 10.4414/smw.2022.w30195. PMID: 35816628.
Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland
Antibiotics 2022, 11, 792. https://doi.org/10.3390/antibiotics 11060792.
Temporal and structural patterns of extended-spectrum cephalosporin-resistant Klebsiella pneumoniae incidence in Swiss hospitals
J Hosp Infect. 120 (2022), p 36-42. PMID: 34798172.
Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018.
Euro Surveill. 2021 Nov;26(46). PMID: 34794535.
The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study.
Crit Care. 2021 Nov 22;25(1):403. doi: 10.1186/s13054-021-03814-z. PMID: 34809698.
The consumption of anti-MRSA antibiotics in Swiss hospitals is associated with antibiotic stewardship measures
Journal of Hospital Infection 117 (2021) 165-171
Distribution of pathogens and antimicrobial resistance in bacteraemia according to hospitalization duration: a nationwide surveillance study in Switzerland
Clin Microbiol Infect. 2021 Apr 30:S1198-743X(21)00212-3.
Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
Euro Surveill. 2020;26(15):pii=1900760. https://doi.org/10.2807/1560-7917. ES.2021.26.15.1900760
Echtzeit-Resistenzstatistik. Bekämpfung von Antibiotikaresistenzen in der Schweiz.
Prim Hosp Care Allg Inn Med. 2020;20(11):352-355
primary hospital care
Vermeidung einer Pandemie mit multiresistenten Mikroorganismen: Lehren aus COVID-19?
SWISS MEDICAL FORUM – SCHWEIZERISCHES MEDIZIN-FORUM 2020;20(47–48):690–694
Swiss Medical Forum
Rapid Increase of CTX-M-Producing Shigella sonnei Isolates in Switzerland Due to Spread of Common Plasmids and International Clones
Antimicrob Agents Chemother. 2020 Sep 21;64(10):e01057-20. doi: 10.1128/AAC.01057-20. PMID: 32718957; PMCID: PMC7508577.
https://boris.unibe.ch/145419/
Treatment of urinary tract infections in Swiss primary care: quality and determinants of antibiotic prescribing
BMC Fam Pract 21, 125 (2020). https://doi.org/10.1186/s12875-020-01201-1
BMC Family Practice
Increasing proportion of vancomycin resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018.
Euro Surveill. 2020;25(35):pii=1900575. https://doi. org/10.2807/1560-7917.ES.2020.25.35.1900575
https://boris.unibe.ch/146425/
Active surveillance of antibiotic resistance patterns in urinary tract infections in primary care in Switzerland.
Infection 2019
boris.unibe.ch/138184
Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland – a systematic review.
Epidemiology and Infection 147, e259, 1–11.
boris.unibe.ch/138185
Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data for a national surveillance network over an 8-year period (2009 – 2016).
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland
Catheter-related infections: does the spectrum of microbial causes change over time? A nationwide surveillance study.
BMJ Open 2018;8:e023824. doi:10.1136
boris.unibe.ch/123005
Aktuelle Entwicklung der Antibiotikaresistenzen in der Schweiz.
Epidemiology of Subsequent Bloodstream Infections in the ICU.
Critical Care (2018) 22:259 (letter).
boris.unibe.ch/120479
Antibiotic resistance in Swiss nursing homes: analysis of National Surveillannce Data over an 11-year pertiod between 2007 and 2017.
Antimicrob Resist Infect Control. 2018 Jul20;7:88.
boris.unibe.ch/125626
Intrahospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae.
Antimicrobial Resistance and Infection Control 2018 Jul 28;7:89.
boris.unibe.ch/119166
Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland.
BMC Infect Dis. 2018 Apr 3; 18(1):159.
boris.unibe.ch/123007
Low incidence of subsequent bateraemia or fungaemia after removal of a colonized intravascular catheter tip.
Clin Microbiol Infect.2018 May; 24(5): 548e1-548e3.
boris.unibe.ch/106097
Characterizing non-linear effects of hospitalisation duration on antimicrobial resistance in respiratory isolates: an analysis of a prospective nationwide surveillance system.
Clin Microbiol Infect. 2018 Jan; 24(19): 45-52.
boris.unibe.ch/101233
Different Epidemiology of Hospital-Acquired Bloodstream Infections Between Small Community Hospitals and Large Community Hospitals.
Clin Infect Dis. 2017 Apr; 64(7): 984-985.
boris.unibe.ch/98994
Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzeralnd 2008-2014.
BMJ open 2017 Mat 21; 7(3): e013665.doi:10.1136/bmjopen-2016-013665.
boris.unibe.ch/98262
Patterns and Trends of Pediatric Bloodstream Infections. A 7-Year Surveillance Study.
J Clin Microbiol Infect Dis. DOI 10.1007/s10096-016-2830-6.
boris.unibe.ch/90765
Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014.
Swiss Med Wkly 2016 Sep 15; 146:w14339.
boris.unibe.ch/91960
National Bloodstream Infecion Surveillance in Switzerland 2008-2014: Different Patterns and Trends for University and Community Hospitals.
Infect Control Hosp Epidemiol 2016; June 28: 1-8 [Epub ahead of print].
boris.unibe.ch/89536
Improvement of Antibiotic Prescription in Outpatient Care: A Cluster-Randomized Intervention Study Using a Sentinel Surveillance Network of Physicians.
J Antimicrob Chemother. 2015 Feb;70(2):602-8.
boris.unibe.ch/59406
A Prospective Multicenter SPOG 2003 FN Study of Microbiologically Defined Infections in Pediatric Cancer Patients with Fever and Neutropenia.
Pediatr Infect Dis J. 2014 Sep;33(9):e219-25.
boris.unibe.ch/47800
Joint report 2013 ARCH-vet anresis.ch. Usage of Antibiotics and Occurence of Antibiotic Resistance in Bacteria from Humans and Animals in Switzerland.
November 2016. FOPH publication number: 2016-OEG-30.
Temporal trends of extended-spectrum cephalosporin resistant Escherichia coli and Klebsiella pneumoniae in Switzerland.
Euro Surveill 2013 May 23; 18(21): 1-10.
boris.unibe.ch/44300
Extended-Spectrum Cephalosporins-Resistant Escherichia coli in Community, Specialized Outpatient Clinics, and Hospital Settings in Switzerland.
J Antimicrob Chemother. 2013 Oct;68(10):2249-54
boris.unibe.ch/43826
Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?
International Journal of Antimicrobial Agents 41 (2013): 236– 249.
Multiresistente Enterokokken.
Swiss Medical Forum 2012;12(42):805-807.
Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis.
Antimicrob Agents Chemother. 2012 Feb;56(2):989-94.
Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe.
J Hosp Infect. 2011 Oct;79(2):166-71.
Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests.
Clin Microbiol Infect. 2011 Jun;17(6):855-61.
Antibiotikaresistenzdaten der Schweiz: jetzt online.
Schweiz Med Forum 2008;8(22):415–418.
Distribution and invasiveness of Streptococcus pneumoniae serotypes in Switzerland, a country with low antibiotic selection pressure, from 2001 to 2004.
J. Clin. Microbiol 2006. 44:2032-8.